Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Vilobelimab augments treatment armamentarium for critically ill COVID-19 patients
29 Nov 2022
bởiAudrey Abella
In the phase III part of the PANAMO trial, the anti-C5a monoclonal antibody vilobelimab, when added to standard of care (SoC), improved survival in COVID-19 patients who required invasive mechanical ventilation (IMV).
29 Nov 2022

Breath-holding may predict adverse outcomes in COVID-19 patients
28 Nov 2022
bởiStephen Padilla
A higher prediction score in breath-holding is associated with nearly a fivefold increased likelihood of respiratory failure in COVID-19 patients, as well as with greater severity of pulmonary deficits seen in chest imaging, a study has shown.
28 Nov 2022






